XML 85 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Summary of Special Items
The following tables present the special items recorded by the Company for the three months ended March 31, 2020 and 2019.
Three Months Ended
(In millions)March 31, 2020March 31, 2019
Description of Special Item Charges (Benefits) and Financial Statement Line Item(s)After-taxBefore-taxAfter-taxBefore-tax
Debt extinguishment costs (Debt extinguishment costs)$140  $185  $—  $—  
Integration and transaction-related costs (Selling, general and administrative expenses)74  97  108  136  
Charge for organizational efficiency plan (Selling, general and administrative expenses)24  31  —  —  
Charges associated with litigation matters (Selling, general and administrative expenses)19  25  —  —  
Contractual adjustment for a former client (Pharmacy revenues)(66) (87) —  —  
Total impact from special items$191  $251  $108  $136  
Summarized Segment Financial Information
Summarized segment financial information for the three months ended March 31 was as follows:
(In millions)Health ServicesIntegrated MedicalInternational MarketsGroup Disability and OtherCorporate and EliminationsTotal
Three months ended March 31, 2020
Revenues from external customers (1)
$26,256  $9,268  $1,420  $1,172  $—  $38,116  
Inter-segment revenues974  466  —   (1,445) 
Net investment income25  126  40  162  —  353  
Total revenues27,255  9,860  1,460  1,339  (1,445) 38,469  
Net realized investment results from certain equity method investments (2)
—  —  10  —  —  10  
Special items(87) —  —  —  —  (87) 
Adjusted revenues$27,168  $9,860  $1,470  $1,339  $(1,445) $38,392  
Income (loss) before taxes$694  $1,140  $234  $72  $(743) $1,397  
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests(4) —  (5) —  —  (9) 
Net realized investment losses (2)
—  48  46   —  98  
Amortization of acquired intangible assets479  11    —  498  
Special items
Debt extinguishment costs—  —  —  —  185  185  
Integration and transaction-related costs—  —  —  —  97  97  
Charge for organizational efficiency plan —  —  —  —  31  31  
Charges associated with litigation matters—  —  —  —  25  25  
Contractual adjustment for a former client(87) —  —  —  —  (87) 
Pre-tax adjusted income (loss) from operations$1,082  $1,199  $282  $77  $(405) $2,235  
(In millions)Health ServicesIntegrated MedicalInternational MarketsGroup Disability and OtherCorporate and EliminationsTotal
Three months ended March 31, 2019
Revenues from external customers (1)
$26,197  $8,910  $1,384  $1,109  $—  $37,600  
Inter-segment revenues737  162  —   (906) 
Net investment income (loss)15  123  38  180  (10) 346  
Total revenues26,949  9,195  1,422  1,296  (916) 37,946  
Revenue contribution from transitioning clients(4,489) —  —  —  —  (4,489) 
Net realized investment results from certain equity method investments (2)
—  —  (28) —  —  (28) 
Adjusted revenues$22,460  $9,195  $1,394  $1,296  $(916) $33,429  
Income (loss) before taxes$942  $1,157  $222  $93  $(626) $1,788  
Pre-tax adjustments to reconcile to adjusted income from operations
Adjustment for transitioning clients(660) —  —  —  —  (660) 
(Income) attributable to noncontrolling interests(1) —  (4) —  —  (5) 
Net realized investment (gains) (2)
—  (5) (23) (10) —  (38) 
Amortization of acquired intangible assets713  18  11   —  743  
Special items
Integration and transaction-related costs—  —  —  —  136  136  
Pre-tax adjusted income (loss) from operations$994  $1,170  $206  $84  $(490) $1,964  
(1)Includes the Company’s share of the earnings of its joint ventures reported in the International Markets segment using the equity method of accounting.
(2)Includes the Company’s share of certain realized investment (gains) losses of its joint ventures reported in the International Markets segment using the equity method of accounting
Revenue from External Customers
Revenue from external customers includes pharmacy revenues, premiums and fees and other revenues. The following table presents these revenues by product, premium and service type for the three months ended March 31:
Three Months Ended March 31,
(In millions)20202019
Products (Pharmacy revenues) (ASC 606)
Network revenues$12,142  $12,273  
Home delivery and specialty revenues11,714  11,784  
Other1,242  1,122  
Total pharmacy revenues25,098  25,179  
Insurance premiums (ASC 944)
Integrated Medical premiums
Commercial
Health Insurance3,461  3,039  
Stop loss1,161  1,069  
Other289  278  
Government
Medicare Advantage1,881  1,607  
Medicare Part D462  525  
Other1,066  1,065  
Total Integrated Medical premiums8,320  7,583  
International Markets premiums1,375  1,304  
Domestic disability, life and accident premiums1,116  1,047  
Other premiums29  37  
Total premiums10,840  9,971  
Services (ASC 606)
Fees2,154  2,390  
Other external revenues24  60  
Total services2,178  2,450  
Total revenues from external customers$38,116  $37,600